Harada Manabu, Tsujimoto Hironori, Ichikura Takashi, Nagata Hiromi, Ito Nozomi, Nomura Shinsuke, Horiguchi Hiroyuki, Yaguchi Yoshihisa, Kishi Yoji, Ueno Hideki
Department of Surgery, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan.
Surg Case Rep. 2019 Jul 1;5(1):106. doi: 10.1186/s40792-019-0664-z.
Alpha-fetoprotein-producing gastric cancer (AFP-GC) is a relatively rare disease, with a dismal prognosis.
We report the case of a patient with long-term survival after surgery for the recurrence of AFP-GC. A 71-year-old man was diagnosed with gastric cancer and underwent distal gastrectomy with D2 lymphadenectomy (pT3N2M0). Pathological examination of the resected specimen revealed AFP-GC. Fifteen years after the gastrectomy, the patient experienced anorexia and was admitted with a mass located at the mesentery of the small intestine. Following a diagnosis of gastrointestinal stromal tumor of the mesentery, a tumor resection with partial small intestine was performed. The final histopathological diagnosis was AFP-GC's recurrence in the small-bowel mesentery. Two months later, multiple liver metastases were identified, and serum AFP level was found to be extremely high (17,447 ng/mL). Chemotherapy with S-1+CDDP (SP) was initiated for liver metastasis. However, owing to anorexia and fatigue, SP therapy was discontinued following the patient's request at the end of two courses. A CT scan at 1 month after the discontinuation of chemotherapy did not reveal liver metastasis, and serum AFP level decreased to the normal range. He is alive at present with no re-recurrence and no elevation of serum AFP level at 7 years after the second surgery without any chemotherapy.
Even if recurrence of AFP-GC is diagnosed, radical resection and chemotherapy are effective, as noted in the present case.
产甲胎蛋白胃癌(AFP-GC)是一种相对罕见的疾病,预后较差。
我们报告一例AFP-GC复发术后长期存活的患者。一名71岁男性被诊断为胃癌,接受了D2淋巴结清扫的远端胃切除术(pT3N2M0)。切除标本的病理检查显示为AFP-GC。胃切除术后15年,患者出现厌食,因小肠系膜处有肿块入院。在诊断为肠系膜胃肠道间质瘤后,进行了小肠部分切除的肿瘤切除术。最终组织病理学诊断为AFP-GC复发于小肠系膜。两个月后,发现多处肝转移,血清甲胎蛋白水平极高(17447 ng/mL)。开始用S-1+顺铂(SP)进行肝转移化疗。然而,由于厌食和疲劳,两个疗程结束后患者要求停止SP治疗。化疗停止1个月后的CT扫描未显示肝转移,血清甲胎蛋白水平降至正常范围。第二次手术后7年,他目前仍存活,未再次复发,血清甲胎蛋白水平未升高,且未接受任何化疗。
如本病例所示,即使诊断为AFP-GC复发,根治性切除和化疗也是有效的。